Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge

American Journal of Rhinology and Allergy

Volumn 27, Issue 4, 2013, Pages 266-272

  Baumann, Ralf ^a   Rabaszowski, Matthaeus ^a   Stenin, Igor ^a   Tilgner, Lisa ^a   Scheckenbach, Kathrin ^a   Wiltfang, Jens ^b   Schipper, Joerg ^a   Chaker, Adam ^c   Wagenmann, Martin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN 3; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 4;

ADULT; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; HAY FEVER; HUMAN; LUMINESCENCE; MALE; NASAL LAVAGE; PERENNIAL RHINITIS; POLLINATION; SEASONAL VARIATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES, CC; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-4; MALE; MIDDLE AGED; MONOCYTE CHEMOATTRACTANT PROTEINS; NASAL LAVAGE FLUID; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS;

EID: 84883433362     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3913     Document Type: Article

References (50)

1. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc 31:370-374, 2010.
2. Uzzaman AA, and Story RR. Chapter 5: Allergic rhinitis. Allergy Asthma Proc 33(suppl 1):15-18, 2012.
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
4. Feng CH, Miller MD, and Simon RA. The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy 26:187-190, 2012.
5. Marple BF. Allergic rhinitis and inflammatory airway disease: Interactions within the unified airspace. Am J Rhinol Allergy 24:249-254, 2010.
6. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375-380, 2010.
7. Holgate ST, and Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 8:218-230, 2008.
8. Akdis CA, Blesken T, Akdis M, et al. Role of interleukin 10 in specific immunotherapy. J Clin Invest 102:98-106, 1998.
9. Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701-21.e1-70, 2011.
10. Xu G, Zhang L, Wang DY, et al. Opposing roles of IL-17A and IL-25 in the regulation of TSLP production in human nasal epithelial cells. Allergy 65:581-589, 2010.
11. Klemens C, Rasp G, Jund F, et al. Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy Asthma Proc 28:434-441, 2007.
12. Wang YH, Voo KS, Liu B, et al. A novel subset of CD4(-) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 207:2479-2491, 2010.
13. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367-1370, 2010.
14. Wang D, Clement P, Smitz J, et al. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 106:278-285, 1995.
15. Wagenmann M, Schumacher L, and Bachert C. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge. Allergy 60:1132-1138, 2005.
16. Boghdadi G, Marei A, Ali A, et al. Immunological markers in allergic rhinitis patients treated with date palm immunotherapy. Inflamm Res 61:719-724, 2012.
17. Benson M, Strannegard IL, Wennergren G, and Strannegard O. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 8:143-149, 1997.
18. Chawes B, Edwards M, Shamji B, et al. A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid. J Allergy Clin Immunol 125:1387-1389.e3, 2010.
19. Quan SH, Zhang YL, Han DH, et al. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann Allergy Asthma Immunol. 108: 342-350, 2012.
20. Ciprandi G, De Amici M, Murdaca G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64: 1375-1378, 2009.
21. Chae SC, Park YR, Oh GJ, et al. The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis. Immunogenetics 56:760-764, 2005.
22. Wang M, Zhang Y, Han D, and Zhang L. Association between polymorphisms in cytokine genes IL-17A and IL-17F and develop-ment of allergic rhinitis and comorbid asthma in Chinese subjects. Hum Immunol 73:647-653, 2012.
23. Mendez-Enriquez E, Melendez Y, Martinez F, et al. CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation. Clin Exp Immunol 152:354-363, 2008.
24. Zhang RX, Yu SQ, Jiang JZ, and Liu GJ. Complementary DNA microarray analysis of chemokines and their receptors in allergic rhinitis. J Investig Allergol Clin Immunol 17:329-336, 2007.
25. Carr TF, and Saltoun CA. Chapter 2: Skin testing in allergy. Allergy Asthma Proc 33:6-8, 2012.
26. Conover WJ. Chapter 5: Some methods based on ranks. Section 5.8 Several related samples -The Friedman test. In Practical Nonparametric Statistics. New York: Wiley, 369-373, 1999.
27. Milovanovic M, Drozdenko G, Weise C, et al. Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol 130:2621-2628, 2010.
28. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194:519-527, 2001.
29. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387, 2002.
30. Ciprandi G, Filaci G, and Fenoglio D. Th17 cells and allergic rhinitis: Is there clinical relevance? Otolaryngol Head Neck Surg 143:604-605, 2010.
31. Kitaura M, Suzuki N, Imai T, et al. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 274:27975-27980, 1999.
32. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, and Pierzchała W. Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge. Allergy Asthma Proc 32:230-238, 2011.
33. Berkman N, Ohnona S, Chung F, and Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol 24:682-687, 2001.
34. Ogilvie P, Paoletti S, Clark-Lewis I, and Uguccioni M. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102:789-794, 2003.
35. Petkovic V, Moghini C, Paoletti S, et al. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. J Biol Chem 279:23357-23363, 2004.
36. Wright ED, Christodoulopoulos P, Small P, et al. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids. Laryngoscope 108:1528-1533, 1998.
37. Pouliot P, Turmel V, Gélinas E, et al. Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 35:804-810, 2005.
38. Vasiliev AM, Vasilenko RN, Kulikova NL, et al. Structural and functional properties of IL-4delta2, an alternative splice variant of human IL-4. J Proteome Res 2:273-281, 2003.
39. Glare EM, Divjak M, Rolland JM, and Walters EH. Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4delta2. J Allergy Clin Immunol 104:978-982, 1999.
40. Yadav A, Govindasamy GK, and Naidu R. Polymorphic variants of interleukin-13 R130Q, interleukin-4 T589C, interleukin-4RA I50V, and interleukin-4RA Q576R in allergic rhinitis: A pilot study. Allergy Rhinol (Providence) 3:e35-e40, 2012.
41. Li Z, Chen L, and Qin Z. Paradoxical roles of IL-4 in tumor immunity. Cell Mol Immunol 6:415-422, 2009.
42. Lu MP, Chen RX, Wang ML, et al. Association study on IL4, IL13 and IL4RA polymorphisms in mite-sensitized persistent allergic rhinitis in a Chinese population. PLoS ONE 6:e27363, 2011.
43. de Guia RM, and Ramos JD. The 590C/TIL4 single-nucleotide polymorphism as a genetic factor of atopic allergy. Int J Mol Epidemiol Genet 1:67-73, 2010.
44. Jeannin P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 160:3555-3561, 1998.
45. Takanaski S, Nonaka R, Xing Z, et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 180:711-715, 1994.
46. Enk AH, Angeloni VL, Udey MC, and Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151:2390-2398, 1993.
47. Meiler F, Zumkehr J, Klunker S, et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med. 205:2887-2898, 2008.
48. Hussein PY, Zahran F, Ashour Wahba A, et al. Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 serum levels in Egyptian atopic patients. J Investig Allergol Clin Immunol 20:20-26, 2010.
49. Benson M, Strannegard IL, Wennergren G, and Strannegard O. Increase of the soluble IL-4 receptor (IL-4sR) and positive correlation between IL-4sR and IgE in nasal fluids from school children with allergic rhinitis. Allergy Asthma Proc 21:89-95, 2000.
50. KleinJan A, Dijkstra MD, Boks SS, et al. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 103: 441-450, 1999.